MONITORING CLINICAL-TRIALS TO TERMINATE ACCRUAL

被引：0

|

作者：

RUBINSTEIN, LV ^{[1
]}

GAIL, MH ^{[1
]}

机构：

[1] NCI,BIOMETRY BRANCH,BETHESDA,MD 20205

来源：

CONTROLLED CLINICAL TRIALS | 1981年 / 2卷 / 01期

关键词：

D O I：

10.1016/0197-2456(81)90060-X

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：67 / 67

页数：1

相关论文

共 50 条

[21] PRIOR PUBLICATION ON MONITORING CLINICAL-TRIALS
WITTES, J
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (06) : 611 - 611
[22] MONITORING OF CLINICAL-TRIALS - ISSUES AND RECOMMENDATIONS
FLEMING, TR
DEMETS, DL
CONTROLLED CLINICAL TRIALS, 1993, 14 (03): : 183 - 197
[23] NCIS CLINICAL-TRIALS MONITORING SERVICE
SMITH, C
ROYDS, R
BONO, V
MARSONI, S
HOTH, D
CONTROLLED CLINICAL TRIALS, 1982, 3 (02): : 148 - 148
[24] DETERMINING THE REQUIRED ACCRUAL RATE FOR FIXED-DURATION CLINICAL-TRIALS
PALTA, M
JOURNAL OF CHRONIC DISEASES, 1982, 35 (01): : 73 - 77
[25] A SURVEY OF MONITORING PRACTICES IN CANCER CLINICAL-TRIALS - DATA MONITORING COMMITTEES FOR SOUTHWEST ONCOLOGY GROUP CLINICAL-TRIALS - DISCUSSION
ELLENBERG, S
CROWLEY, J
MEINERT, C
GEORGE, S
POCOCK, S
ARMITAGE, P
SIMON, R
YUSUF, S
WITTES, J
STATISTICS IN MEDICINE, 1993, 12 (5-6) : 457 - 459
[26] NONPARAMETRIC-ESTIMATION OF DURATION OF ACCRUAL AND TOTAL STUDY LENGTH FOR CLINICAL-TRIALS
MORGAN, TM
BIOMETRICS, 1987, 43 (04) : 903 - 912
[27] A SURVEY OF MONITORING PRACTICES IN CANCER CLINICAL-TRIALS
GEORGE, SL
STATISTICS IN MEDICINE, 1993, 12 (5-6) : 435 - 450
[28] SAFETY AND DATA MONITORING COMMITTEES FOR CLINICAL-TRIALS
CONTI, CR
CLINICAL CARDIOLOGY, 1995, 18 (08) : 432 - 432
[29] DATA-MONITORING COMMITTEES IN CLINICAL-TRIALS
SLEIGHT, P
LANCET, 1993, 341 (8854): : 1219 - 1220
[30] ROBUST BAYESIAN METHODS FOR MONITORING CLINICAL-TRIALS
GREENHOUSE, JB
WASSERMAN, L
STATISTICS IN MEDICINE, 1995, 14 (12) : 1379 - 1391

← 1 2 3 4 5 →